The Alethium team is excited to travel to London for Advanced Therapies Congress, Europe’s largest cell and gene therapy conference and exhibition, happening March 19-20th. This event brings together the world leaders in ATMP development and technology that are driving the industry forward.

Inspired by 250 speakers and 100 start-ups, the Advanced Therapies Congress features speakers from across the entire value chain of cell and gene therapy development; forward-thinking pharma, biotech and startup companies, researchers, clinicians, academics, HTAs, payers, and regulators.

Here at Alethium Health, we are thrilled about our role in supporting the next-generation of clinical research through our robust digital platform focused on patient-centric and value-driven solutions. The Alethium eClinical Platform is automated to scale in real-time across multiple languages without incurring extra costs or schedule disruptions. Operating as a small and singularly focused team with a full suite of services, Alethium is devoted to the success of each trial, regardless of their stakes or risk factors.